• 1. An amino group functionalized metal–organic framework as a luminescent probe for highly selective sensing of Fe3+ ions?
  Zhonghua Xiang,Chuanqi Fang,Sanhua Leng,Dapeng Cao J. Mater. Chem. A, 2014,2, 7662-7665
• 2. An artificial photosynthetic system for photoaccumulation of two electrons on a fused dipyridophenazine (dppz)–pyridoquinolinone ligand?
  Philipp Traber,Stephan Kupfer,Stefanie Gr?fe,Isabelle Baussanne,Martine Demeunynck,Jean-Marie Mouesca,Serge Gambarelli,Vincent Artero,Murielle Chavarot-Kerlidou Chem. Sci., 2018,9, 4152-4159
• 3. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 4. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 5. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazole carboxylic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazoles Pyrazole carboxylic acids and derivatives

Introduction to 5-amino-1-(propan-2-yl)-1H-pyrazole-4-carboxylic acid (CAS No. 26262-07-7)

5-amino-1-(propan-2-yl)-1H-pyrazole-4-carboxylic acid, identified by the chemical identifier CAS No. 26262-07-7, is a significant compound in the realm of pharmaceutical chemistry and bioorganic synthesis. This heterocyclic derivative belongs to the pyrazole family, a class of molecules renowned for their diverse biological activities and structural versatility. The presence of both amino and carboxylic acid functional groups, coupled with an isopropyl substituent at the 1-position, makes this compound a versatile intermediate in the synthesis of more complex pharmacophores.

The structural framework of 5-amino-1-(propan-2-yl)-1H-pyrazole-4-carboxylic acid imparts unique reactivity that has garnered attention in medicinal chemistry. The amino group at the 5-position serves as a potential site for further derivatization, enabling the formation of amides, ureas, or sulfonamides, which are common motifs in drug design. Concurrently, the carboxylic acid functionality at the 4-position allows for esterification or amidation, expanding its utility in constructing biologically active molecules.

Recent advancements in computational chemistry and molecular modeling have highlighted the potential of pyrazole derivatives as scaffolds for drug development. Studies indicate that compounds incorporating the pyrazole core exhibit inhibitory activity against various enzymes and receptors implicated in metabolic disorders, inflammatory diseases, and cancer. Specifically, 5-amino-1-(propan-2-yl)-1H-pyrazole-4-carboxylic acid has been investigated for its role in modulating pathways involving kinases and other enzyme targets.

In the context of modern drug discovery, the synthesis of 5-amino-1-(propan-2-yl)-1H-pyrazole-4-carboxylic acid has been optimized through multi-step organic transformations, leveraging catalytic methods to enhance efficiency and yield. The isopropyl group at the 1-position contributes to steric hindrance, which can be exploited to fine-tune binding interactions with biological targets. This feature has been particularly useful in designing molecules with improved selectivity over off-target proteins.

One notable application of this compound lies in its use as a precursor for more complex heterocycles. For instance, it can be cyclized or coupled with other fragments to generate fused systems such as triazoles or tetrazoles, which are prevalent in modern therapeutic agents. The versatility of 5-amino-1-(propan-2-yl)-1H-pyrazole-4-carboxylic acid underscores its importance as a building block in synthetic chemistry.

The pharmacological profile of derivatives derived from CAS No. 26262-07-7 has been explored through both in vitro and in vivo studies. Initial assays have revealed promising activities against certain cancer cell lines, where modifications to the pyrazole core have led to enhanced cytotoxicity without significant toxicity to normal cells. Additionally, preclinical models have demonstrated potential therapeutic effects in inflammatory conditions, suggesting its utility beyond oncology applications.

The synthesis and functionalization of 5-amino-1-(propan-2-yl)-1H-pyrazole-4-carboxylic acid have also been integrated into flow chemistry protocols, enabling scalable production under mild conditions. This approach aligns with green chemistry principles by reducing solvent waste and energy consumption. Such advancements are critical in ensuring sustainable practices within pharmaceutical manufacturing.

Future directions in the study of CAS No. 26262-07-7 may involve exploring its role in developing treatments for neurodegenerative diseases. Pyrazole derivatives have shown potential as modulators of neurotransmitter systems, and further investigation into the pharmacodynamics of this compound could uncover novel therapeutic strategies. Collaborative efforts between synthetic chemists and biologists will be essential to translate these findings into clinical applications.

In summary, 5-amino-1-(propan-2-yl)-1H-pyrazole-4-carboxylic acid (CAS No. 26262-07-7) represents a valuable asset in medicinal chemistry due to its structural features and biological relevance. Its role as a synthetic intermediate and pharmacophore continues to be explored through interdisciplinary research efforts aimed at addressing unmet medical needs.

• 58046-50-7(5-Amino-1-(2-hydroxyethyl)-1H-pyrazole-4-carboxylic acid)
• 1007513-71-4(5-amino-1-(2-cyanoethyl)-1H-pyrazole-4-carboxylic acid)
• 1788527-71-8(3-Amino-1-ethyl-1H-pyrazole-4-carboxylic acid)
• 1759-24-6(ethyl 5-amino-1-(propan-2-yl)-1H-pyrazole-4-carboxylate)
• 112779-14-3(ethyl 5-amino-1-tert-butyl-pyrazole-4-carboxylate)
• 157436-82-3(1H-Pyrazole-4-carboxylicacid,5-amino-1-(2,3-dihydroxypropyl)-(9CI))
• 1554878-52-2(5-amino-1-propyl-1H-pyrazole-4-carboxylic acid)
• 1246552-38-4(5-Amino-1-ethyl-1H-pyrazole-4-carboxylic acid)
• 1545779-06-3(5-amino-1-tert-butyl-1H-pyrazole-4-carboxylic acid)
• 1365623-60-4(Ethyl 5-amino-1-isopropyl-1H-pyrazole-4-carboxylate)